Divis Laboratories Ltd (DIVISLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,773.00",
    "chg": 112.9,
    "chgp": "1.7%",
    "dir": 1,
    "prev_price": "6,660.10",
    "mcapval": "176,677.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "4.16 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4000096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_4000096.png",
        "date": "2026-05-20 08:01:52",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. This change has prompted an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Golden Cross Confirmed: Do Divis Laboratories Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3999496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_goldencross_3999496.png",
        "date": "2026-05-19 18:00:16",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Divis Laboratories Ltd, signalling a golden cross on 19 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3986436",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3986436.png",
        "date": "2026-05-12 08:03:37",
        "description": "Divis Laboratories Ltd has experienced a subtle but notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment for this large-cap pharmaceutical player."
      },
      {
        "title": "Divis Laboratories Gains 1.37%: Technical Stabilisation and Financial Strength Drive Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-137-technical-stabilisation-and-financial-strength-drive-week-3983608",
        "imagepath": "",
        "date": "2026-05-09 17:06:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.6,618.20</p>\n                    <p><strong>5 May:</strong> Mojo Grade upgraded to Hold by MarketsMOJO</p>\n                    <p><strong>6 May:</strong> Stock gains 0.80% amid strong Sensex rally</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.6,708.90 (+1.37%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,618.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6,708.90</div><div class=\"stat-change positive\">+1.37%</div></di..."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-stabilisation-amid-mixed-indicators-3974767",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3974767.png",
        "date": "2026-05-05 08:03:01",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-3961148",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3961148.png",
        "date": "2026-04-24 15:00:30",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.58% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the underlying volume and futures data suggest a complex interplay of bullish and cautious sentiment among traders."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3961020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3961020.png",
        "date": "2026-04-24 14:00:19",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.14% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline of 0.33% on 24 Apr 2026, the stock outperformed its sector by 1.49%, reflecting complex underlying dynamics in trading behaviour and sentiment."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3959458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3959458.png",
        "date": "2026-04-23 15:00:24",
        "description": "Divis Laboratories Ltd, a large-cap pharmaceutical heavyweight, has witnessed a notable 13.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector on 23 Apr 2026, reflecting a complex interplay between bullish bets and cautious sentiment."
      },
      {
        "title": "Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-notable-surge-in-derivatives-open-interest-amid-mixed-market-signals-3957732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3957732.png",
        "date": "2026-04-22 15:00:12",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite this increase, the stock’s performance remains largely in line with its sector peers, reflecting a nuanced market sentiment amid broader index weakness."
      }
    ],
    "total": 15,
    "sid": "509760",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26",
      "datetime": "11-Jun-2026",
      "details": "As per enclosed letter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Jun-2026",
      "details": "Copies of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividends and equity shares to IEPF",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "29-May-2026",
      "details": "Submission of transcript of Earnings Conference Call held on May 23 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-20 08:01:52

Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. This change has prompted an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector.

Golden Cross Confirmed: Do Divis Laboratories Ltd's Other Technical Indicators Agree?

2026-05-19 18:00:16

The 50-day moving average has crossed above the 200-day moving average for Divis Laboratories Ltd, signalling a golden cross on 19 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination.

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-12 08:03:37

Divis Laboratories Ltd has experienced a subtle but notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment for this large-cap pharmaceutical player.

Divis Laboratories Gains 1.37%: Technical Stabilisation and Financial Strength Drive Week

2026-05-09 17:06:16

Key Events This Week 4 May: Week opens at Rs.6,618.20 5 May: Mojo Grade upgraded to Hold by MarketsMOJO 6 May: Stock gains 0.80% amid strong Sensex rally 8 May: Week closes at Rs.6,708.90 (+1.37%) Week OpenRs.6,618.20 Week CloseRs.6,708.90+1.37%</di...

Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators

2026-05-05 08:03:01

Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations.

Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-04-24 15:00:30

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.58% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the underlying volume and futures data suggest a complex interplay of bullish and cautious sentiment among traders.

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-24 14:00:19

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.14% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline of 0.33% on 24 Apr 2026, the stock outperformed its sector by 1.49%, reflecting complex underlying dynamics in trading behaviour and sentiment.

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-23 15:00:24

Divis Laboratories Ltd, a large-cap pharmaceutical heavyweight, has witnessed a notable 13.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector on 23 Apr 2026, reflecting a complex interplay between bullish bets and cautious sentiment.

Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Mixed Market Signals

2026-04-22 15:00:12

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite this increase, the stock’s performance remains largely in line with its sector peers, reflecting a nuanced market sentiment amid broader index weakness.

View All News